Log In
Print
BCIQ
Print
Print this Print this
 

Nexavar, sorafenib

Also known as: formerly BAY 43-9006

  Manage Alerts
Collapse Summary General Information
Company Onyx Pharmaceuticals Inc.
DescriptionInhibitor of RAF1 and multiple receptor tyrosine kinases
Molecular Target CRAF (RAF1) ; Vascular endothelial growth factor (VEGF) receptor
Mechanism of ActionRaf inhibitor; FMS-like tyrosine kinase 3 (FLT3) agonist; Platelet derived growth factor receptor (PDGFR) kinase inhibitor; Stem cell factor (SCF) receptor tyrosine kinase (c-Kit) (KIT)(CD117) agonist; Vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) antagonist; Vascular endothelial growth factor (VEGF) receptor 1 (Flt-1) kinase inhibitor
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today